AWM
PCRX icon

Axxcess Wealth Management’s Pacira BioSciences PCRX Stock Holding History

Axxcess Wealth Management’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-3,895
Closed -$207K – 658
2022
Q3 		$207K Hold
3,895
– – 0.02% 493
2022
Q2 		$227K Buy
3,895
+730
+23% +$47.8K 0.02% 466
2022
Q1 		$242K Buy
+3,165
New +$211K 0.02% 536

Other funds holding PCRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return

Axxcess Wealth Management's PCRX Position: Q4 2022 in Review

Axxcess Wealth Management sold out of Pacira BioSciences (PCRX) in Q4 2022, closing a stake of 3,895 shares — an estimated $207K sold.

Axxcess Wealth Management first reported a position in PCRX in Q1 2022 and held it in 3 quarters. The position peaked at $242K in Q1 2022. 273 funds tracked by Wall St. Rank hold PCRX as of Q4 2022.

  • Axxcess Wealth Management reported no remaining Pacira BioSciences position as of Q4 2022 after selling out during the quarter.
  • Axxcess Wealth Management sold 3,895 Pacira BioSciences shares in Q4 2022, an estimated $207K.
  • Axxcess Wealth Management first reported a position in Pacira BioSciences in Q1 2022 and held it in 3 quarters.
  • Axxcess Wealth Management's Pacira BioSciences position peaked at $242K in Q1 2022.
  • 273 funds tracked by Wall St. Rank held Pacira BioSciences as of Q4 2022.

Based on Axxcess Wealth Management's 13F filing for Q4 2022, filed 14 Feb 2023.